Yung Shin Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YUNG SHIN PHARM, and what generic and branded alternatives to YUNG SHIN PHARM drugs are available?
YUNG SHIN PHARM has fifteen approved drugs.
Drugs and US Patents for Yung Shin Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yung Shin Pharm | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 065412-001 | Feb 17, 2012 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Yung Shin Pharm | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 065412-003 | Feb 17, 2012 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Yung Shin Pharm | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 204800-002 | Apr 29, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.